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Conditioning Mechanism of ANV
Many studies in adult patients confirm that the development of ANV involves elements of classical conditioning. 5, [9] [10] [11] Classical conditioning is also known as Pavlovian conditioning, after the Russian scientist who was able to induce dogs to salivate at the sound of a bell that had been repeatedly paired with the ingestion of food. In this paradigm, an unconditioned response (salivation) that typically results from an unconditioned stimulus (the presentation of a food pellet) can be elicited by a conditioned stimulus (the ringing of a bell) that is present at the same time as the unconditioned stimulus.
This paradigm applies to chemotherapy treatment. Figure 1 shows how a conditioning model might account for the development of anticipatory side effects. Nausea and vomiting (NV) after the administration of chemotherapy have been reported by patients since the drugs were first used to treat cancer. Since that time, advances in pharmacologic control of chemotherapyinduced NV have improved symptom management. However, even now, cancer patients may fear the treatment and its side effects more than the disease. Furthermore, chemotherapy-related NV is often associated with physiologic complications, such as fatigue, muscle strain, and metabolic imbalance.
1 They can also contribute to inadequate caloric and fluid intake that can Potential conditioned stimuli (e.g., the sight of the nurse, the room, or other sights, sounds, or smells of the clinic) are present while the unconditioned stimulus (chemotherapeutic agents) that produces the unconditioned response (nausea and emesis) are administered. Over several trials (chemotherapy cycles), the conditioned response stimuli (sights, sounds, and even thoughts of the clinic) can be learned and then produce the conditioned response of ANV. No data convincingly contradict the conclusion that ANV is conditioned. Among the supporting lines of evidence are the following:
• Anticipatory side effects do not develop unless posttreatment side effects have occurred. Few patients in our series of more than 4000 developed anticipatory nausea without experiencing posttreatment nausea at least once. The more severe the posttreatment NV, the greater the likelihood patients developed ANV.
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• Conditioning is more successful with a greater number of repeated trials. Studies have shown that the frequency of ANV increases linearly with the number of chemotherapy cycles given. 3, 8, 13, 14 Each of the studies reports that by the fourth treatment cycle, approximately 20% to 35% of patients experience anticipatory side effects.
Although most researchers agree that the development of ANV is strongly related to the Pavlovian conditioning model, evidence suggests that other cognitive factors, such as anxiety and response expectancies, may play an important role. Anxiety and expectancy are believed to be mediators in a patient's conditioning towards ANV. Researchers hypothesize that conditioning is one method of developing response expectancies. Kirsch et al. 15 hypothesize that a change in response expectancies may, in fact, lead to a reduction of anxiety and thus reduce ANV. 16 Our research unit conducted an illustrative study in 63 female cancer patients with various cancer diagnoses. The patients' expectations for nausea were assessed before their first treatment on a numeric semantic rating scale, ranging from 1 ("I am certain I will not have nausea") to 5 ("I am certain I will have nausea"). Responses to this question were highly predictive of ANV before the third chemotherapy treatment (P = .001), with none of the women who responded with scores of 1 or 2 developing ANV compared with 55% of those who selected a score of 5.
17

Prevention and Treatment of ANV
Traditionally, pharmacologic interventions such as 5-HT3 receptor antagonist and dexamethasone have been used to treat chemotherapy-induced NV, and have been found effective among 65% to 80% of patients. 18 The need to help more patients experience emetic control has led to the use of potentially more effective pharmacologic agents, such as olanzapine, gabapentin, and cannabinoids. 19 In addition, preliminary work by Razavi et al. 8 suggests that low-dose alprazolam (0.5-2 mg) ingested daily may be a potentially useful pharmacologic intervention. Their double-blind, placebo-controlled study of 57 women with breast cancer in a psychological support program, which included progressive muscle relaxation training, found that those in the placebo arm experienced a significantly higher occurrence of anticipatory nausea (18% vs. 0%) than those in the alprazolam arm (P = .038). This observed significant difference was found in the first 2 chemotherapy cycles but not in later treatments.
In another randomized trial evaluating the efficacy of lorazepam in managing anticipatory, acute, and delayed vomiting induced by high doses of cisplatin, 180 events involving cisplatin administration were randomized to receive clemastine with and without lorazepam and metoclopramide along with dexamathasone. 20 Researchers found that lorazepam significantly reduced the incidence of ANV and acute emesis (both, P Յ .05).
Despite the potential benefits, the decision to use antiemetics is often influenced by many factors, including drug effectiveness and possible occurrence of debilitating side effects. In addition, confirmatory analyses are still needed to determine the effectiveness of antiemetics such as gabapentin and cannabinoids. 19 Noticeable increases in the use of alternative and behavioral treatment of chemotherapy-induced NV have been observed recently. The noninvasiveness and lack of negative side effects of behavioral interventions have contributed to patients' willingness to use these methods to control emesis. The following sections discuss various alternative and behavioral methods that have been used to treat cancer patients.
Acupuncture/Acupressure
According to the National Institutes of Health Consensus Development Panel, acupuncture is effective in treating postoperative and chemotherapyrelated NV. A study of acupuncture and acupressure for chemotherapy-induced NV 21 and an interim analysis of acupuncture against chemotherapy-induced NV in pediatric patients 22 showed similar findings. No studies, however, have found any definitive evidence supporting the use of acupuncture and acupressure in alleviating ANV. Only one study provides evidence supporting the use of acupuncture in treating nervous vomiting in a dental setting. 23 
Behavioral Treatment
As a conditioned phenomenon, ANV is treatable through behavioral interventions based on learning principles. Research on the behavioral approaches in treating ANV has focused on 4 principal approaches: progressive muscle relaxation training (PMRT), systematic desensitization, hypnosis, and cognitive distraction. PMRT: PMRT allows individuals to achieve a state of muscle relaxation in anticipation of or in response to various specific situations that may produce tension or anxiety, such as undergoing chemotherapy. A series of randomized clinical trials has shown the efficacy of relaxation-based behavioral treatments. [24] [25] [26] The technique involves learning to relax by actively stretching and then relaxing specific muscle groups in a progressive manner. This method is often combined with guided imagery in which the individual visualizes pleasant, soothing images or scenes while relaxed. PMRT is generally taught to patients by a trained therapist, and then patients are requested to practice the technique at home using an audiotape made during the training session or a set of written instructions.
The ability of patients to put themselves in a relaxed state after one or, at most, a few therapist-directed sessions can enhance the cost-effectiveness of the procedure by limiting therapist involvement and can facilitate its continued effectiveness over time. [27] [28] [29] [30] [31] One randomized study, however, showed that the use of an audio tape alone was not effective in teaching patients with ANV to relax before being exposed to a systematic desensitization (SD) procedure. 32 PMRT seems to exert its strongest influence against adverse events, including postchemotherapy NV, anxiety, and physiologic (autonomic) arousal, that develop after chemotherapy is administered. It has been less effective against anticipatory symptoms.
28-30,33,34 PMRT plus guided imagery, which also results in less nausea during chemotherapy, can prevent the development of conditioned side effects and can also decrease the frequency and severity of conditioned side effects that have already developed. 33, 35 It may prevent the development of ANV by decreasing anticipatory anxiety, which is believed to be a factor in the production of conditioned side effects, especially in patients using a repressive coping style.
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SD:
The technique of SD, commonly used to treat learning-based difficulties such as fears and phobias, is particularly effective for treating ANV. Some phobias may develop through conditioning as previously described. In many respects, anticipatory side effects display characteristics of phobic behaviors, although the match is still far from perfect. Nonetheless, a learning-based treatment approach reduces ANV.
SD involves the counterconditioning of a response incompatible with the stimuli that typically elicit a maladaptive response. Applying SD to ANV, the theory predicts that anticipatory symptoms would be reduced if patients could be taught an incompatible response (e.g., muscle relaxation), rather than the conditioned response of NV, in response to the conditioned stimuli (e.g., the clinic, the nurse).
In this approach, patients are taught an active behavioral intervention called Jacobsonian progressive muscle relaxation. The patient actively constructs a hierarchy of stimuli that seem to elicit the ANV. This hierarchy typically involves moving progressively closer to the setting where the chemotherapy is administered. For example, patients typically start experiencing ANV a day or two before chemotherapy as they begin thinking about it. The intensity of ANV often increases on the morning of the chemotherapy visit and increases even more as patients drive to the clinic. Symptoms further increase as patients walk toward the hospital, approach the door of the treatment center, enter the room where treatment is administered, and see the drug-administration apparatus. SD operates by encouraging patients to imagine undergoing this sequence while they are deeply relaxed. Instead of learning feelings of nausea as a response to the chemotherapy experience, relaxation is counterconditioned as a response. We and other experts have found this treatment to be successful in more than half of patients in whom it has been administered. 24, 34, [37] [38] [39] Other clinical trials have shown that these behavioral techniques can be taught to oncologists and oncology nurses. We have taught this treatment approach to oncologists, nurses, and other behavioral psychologists. 25 The results of this study showed that medical oncologists and nurses were as effective in using this treatment as were experienced behavioral psychologists. Therefore, with proper instruction, this treatment approach can be learned and used successfully by clinic personnel. It does, however, require time and effort that may not be available in all treatment situations. Hypnosis: Hypnosis, also known as suggestive or trance therapy, is a self-control technique in which patients learn to invoke a physiologic state incompatible with NV. In the method usually used to produce the altered state of consciousness, induction of total body relaxation is followed by presentation of restful psychic imagery. While hypnotized, patients can be given suggestions for specific treatment objectives, such as increasing food intake or undergoing chemotherapy. 40 Furthermore, while in hypnosis, patients can be led through a series of events (e.g., those associated with ANV) in a technique similar to SD.
Hypnosis involves a passive type of muscle relaxation and, possibly, also distraction. [40] [41] [42] [43] Although the initial sessions are usually therapist-directed, some patients can learn to induce the state themselves. Thus, a therapist need not be present during chemotherapy. 40 Hypnosis has been used successfully to prevent anticipatory nausea related to chemotherapy 44, 45 and to reduce nausea after chemotherapy. [46] [47] [48] Hypnosis is most often used with children and adolescents, possibly because children are more readily hypnotized than adults. 49 In a controlled experiment, Cotanch et al. 41 randomly assigned 12 youths aged 10 to 18 years to undergo either a relaxation/self-hypnosis intervention or standard treatment. The intervention significantly reduced the frequency, severity, and duration of chemotherapy-related emesis and the intensity and duration of nausea. Oral intake was also significantly improved, and the patients reported feeling less concerned by the chemotherapy experience.
Zeltzer et al. 50 compared hypnotherapy with supportive counseling and suggested that nonspecific therapy effects, such as demand characteristics or attention, may contribute in reducing NV after chemotherapy. In their study, 19 youths aged 6 to 17 years were randomly assigned to a hypnotherapy or supportive counseling group. Youths in both groups reported reductions in NV and rated chemotherapy as "less noxious" after intervention. However, no statistically or clinically significant differences in outcomes were found between the 2 approaches, whereas a later study by Zeltzer et al. 47 with 54 pediatric cancer patients showed a significant reduction in the hypnotherapy group compared with the nonhypnotic distraction/relaxation group or the attention placebo (control) group.
Overall, it seems that studies using hypnosis for ANV control support the benefit of this intervention for children. Less evidence is available illustrating its usefulness for adults. To establish the effectiveness of hypnotherapy for cancer chemotherapy patients, studies with larger sample sizes are needed that randomly assign patients to treatment or appropriate control groups.
Hypnosis certainly has its advantages: it has no undesirable side effects, little training is needed to learn the induction techniques, no special equipment is needed, and it requires little physical effort on the patient's part. Misconceptions about the procedure, however, may lead some patients to refuse to try it. 9 Cultural and religious factors may also play a role in patient acceptance of hypnosis. 51 In summary, hypnosis can reduce anticipatory and postchemotherapy NV and improve quality of life.
50
Cognitive Distraction: Cognitive distraction (CD) may be the common element responsible for the success of relaxation training and hypnosis in decreasing conditioned nausea in adult patients undergoing chemotherapy for cancer. 42, 52 CD causes patients to focus their attention away from NV or the stimuli associated with these phenomena. 52 Using commercially available video games as distraction, Redd et al. 52 examined this hypothesis in 2 studies of pediatric patients with documented ANV from cancer chemotherapy. In the first study, 26 children were randomly assigned to the video game intervention or a control group; in the second, 15 of the 26 children were studied using a multiple-baseline design in which the nausea was assessed with and without video game playing in the same group of children. In both studies, patients experienced significant reductions in conditioned nausea after video games. The changes in nausea could not be attributed to either antiemetic medication or physical relaxation (which did not occur).
In the first controlled study of CD in adults, 60 patients, stratified by level of anxiety, were randomly assigned to undergo CD (video games), PMRT with guided imagery, or no intervention, and were followed up through 5 consecutive chemotherapy sessions during which antiemetic medication was kept relatively constant. Patients undergoing either intervention experienced significantly less nausea before chemotherapy than those in the control condition, and no significant differences in nausea or other outcome measures occurred between the 2 treatment groups. Anxiety level did not influence the effectiveness of either treatment modality. 53 These investigators and others 43, 52 concluded that CD, by interfering with the development or expression of ANV, is responsible for at least some of the effects of PMRT on reducing this conditioned side effect.
CD may be an attractive alternative for pediatric patients, who sometimes have difficulty mastering relaxation and hypnosis. 52 Furthermore, it could be a cost-effective method because it does not require administration by a therapist. 52, 53 Video games, in particular, are inexpensive effective distracters that can be individualized, require no training and minimal assistance, and can result in sustained distraction over time. 42 However, the effects have been noted to decrease over successive chemotherapy sessions. 53 The effect also only persists as long as the CD technique is being used.
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Summary
It is apparent that multiple mechanisms operate at different points in time to cause NV after chemotherapy and that currently available pharmacologic agents may be unable to provide complete protection from ANV associated with chemotherapy treatment. A multidisciplinary approach has been advocated that includes the best possible pharmacologic control of postchemotherapy NV, adequate information provided to patients to modify their expectations, drugs prescribed as needed to decrease anxiety, and adjunctive behavioral treatment, ideally given prophylactically. 40, [54] [55] [56] [57] Furthermore, if ANV is caused by a behavioral process (i.e., a classical conditioning), behavioral interventions may be particularly appropriate for treatment. In addition, behavioral interventions that prevent the development or decrease the severity of posttreatment NV may prevent the occurrence of ANV. Future studies are needed to help determine effective ways in which behavioral interventions could be integrated into the clinical practice guidelines.
